Note: always check the prescribing information and your local formulary.
Administration | Oral |
Starting dose | 2 mg for short-acting immediate-release products
5 mg for controlled-release products |
Frequency | Every 4 hours for short-acting immediate-release products
Every 12 hours for controlled release products |
Monitoring | Renal function |
Comments | eGFR < 30 mL/min: risk of accumulation, consider dose reduction.
Provide breakthrough reserve by using short-acting immediate-release oxycodone (1/6 to 1/10 of daily dose). |